Tessa Therapeutics Forges $120 Million Joint Venture to Develop Cell Therapies in China
snippet
Singapore-based Tessa Therapeutics announced a joint venture with China-Singapore Guangzhou Knowledge City (CSGKC) to leverage Tessa’s cell therapies for development of cancer therapies in China.
Source
BioSpace